Black Rock Inc. Adma Biologics, Inc. Transaction History

Black Rock Inc.

$4.23 Trillion
Q1 2024

A detailed history of Black Rock Inc. transactions in Adma Biologics, Inc. stock. As of the latest transaction made, Black Rock Inc. holds 18,199,277 shares of ADMA stock, worth $203 Million. This represents 0.0% of its overall portfolio holdings.

Number of Shares

18,199,277

Previous 17,917,745 1.57%

Holding current value

$203 Million

Previous $81 Million 48.31%

% of portfolio

0.0%

Previous 0.0%

12 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 May 10, 2024	BUY	$4.4 - $6.74 $1.24 Million - $1.9 Million	281,532 Added 1.57%	18,199,277 $120 Million
Q4 2023 Feb 13, 2024	BUY	$3.08 - $4.52 $3.88 Million - $5.69 Million	1,259,538 Added 7.56%	17,917,745 $81 Million
Q3 2023 Nov 13, 2023	BUY	$3.47 - $4.61 $1.02 Million - $1.35 Million	293,085 Added 1.79%	16,658,207 $59.6 Million
Q2 2023 Aug 11, 2023	SELL	$3.12 - $4.22 $81,734 - $110,551	-26,197 Reduced 0.16%	16,365,122 $60.4 Million
Q1 2023 May 12, 2023	BUY	$3.01 - $3.87 $3.88 Million - $4.99 Million	1,290,038 Added 8.54%	16,391,319 $54.3 Million

Q4 2022 Feb 13, 2023	BUY	$2.47 - $3.88 $5.25 Million - $8.25 Million	2,125,687 Added 16.38%	15,101,281 $58.6 Million
Q3 2022 Nov 14, 2022	BUY	$2.03 - $2.86 $781,282 - $1.1 Million	384,868 Added 3.06%	12,975,594 $31.5 Million
Q2 2022 Aug 12, 2022	BUY	$1.43 - $2.2 $12.1 Million - $18.7 Million	8,483,344 Added 206.54%	12,590,726 $24.9 Million
Q1 2022 May 12, 2022	BUY	$1.28 - $1.83 $40,692 - $58,177	31,791 Added 0.78%	4,107,382 $7.52 Million
Q4 2021 Feb 10, 2022	BUY	$1.09 - $1.66 $1.88 Million - $2.86 Million	1,724,224 Added 73.33%	4,075,591 $5.75 Million
Q3 2021 Nov 09, 2021	BUY	$1.13 - $1.65 $195,642 - $285,672	173,135 Added 7.95%	2,351,367 $2.66 Million
Q2 2021 Aug 11, 2021	BUY	$1.51 - $2.07 $3.29 Million - $4.51 Million	2,178,232 New	2,178,232 $3.48 Million

Others Institutions Holding ADMA

# of Institutions

224

Shares Held

174M

Call Options Held

85.5K

Put Options Held

12.8K

View Full List

About ADMA BIOLOGICS, INC.

Ticker ADMA
Exchange NASDAQ
Sector Healthcare
Industry Biotechnology
Shares Outstandng 196,356,992
Market Cap $2.2B
Description
ADMA Biologics, Inc., a biopharmaceutical company, engages in developing, manufacturing, and marketing specialty plasma-derived biologics for the treatment of immune deficiencies and infectious diseases in the United States and internationally. It offers BIVIGAM, an intravenous immune globulin (IVIG) product indicated for the treatment of primar...

More about ADMA

Track This Portfolio

Portfolio Update

Get notified when there are updates to the investment portfolio of Black Rock Inc., based on Form 13F filings with the SEC.

News

Stay updated on Black Rock Inc. with notifications on news.

Account